Lista de obras - Massimo Martino - Dominio Público Uruguay

'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization

artículo científico publicado en 2005

A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model

artículo científico publicado en 2017

A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant

scientific article published on 18 December 2019

A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study

artículo científico publicado en 2014

A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.

artículo científico publicado en 2012

A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy

artículo científico publicado en 2016

Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.

artículo científico publicado en 2013

Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients

artículo científico publicado en 2004

Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs.

artículo científico

An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma

scientific article published on 18 November 2019

An old drug with a new future: bendamustine in multiple myeloma.

artículo científico publicado en 2013

An update on B-cell maturation antigen-targeted therapies in Multiple Myeloma

scientific article published on 08 January 2021

Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management?

artículo científico publicado en 2012

Autologous stem cell transplantation in multiple myeloma is not dead but alive and well.

artículo científico publicado en 2014

Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study.

artículo científico publicado en 2017

Basiliximab for the treatment of graft rejection in haploidentical peripheral blood stem cell transplantation

scientific article published on 01 December 2002

Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia

scientific article published on 11 May 2020

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

artículo científico

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

artículo científico publicado en 2006

Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting

artículo científico publicado en 2005

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review

artículo científico publicado en 2015

Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma.

artículo científico publicado en 2017

Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.

artículo científico

Diagnostic approaches for identifying acute graft-versus-host disease: what comes next?

artículo científico publicado en 2013

Differences in transplant-related complications between hematologic malignancies and solid tumors receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantation.

artículo científico publicado en 2003

Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation

artículo científico publicado en 2005

Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor

artículo científico publicado en 2012

Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients

artículo científico publicado en 2015

Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation

artículo científico publicado en 2014

Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma

artículo científico publicado en 2013

Graft-versus-lymphoma effect in a patient with a refractory low-grade lymphoma

scientific article published on 01 December 1999

Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim

artículo científico publicado en 2005

High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.

artículo científico publicado en 2015

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry

artículo científico publicado en 2015

High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study.

artículo científico publicado en 2015

High-dose chemotherapy for germ cell tumors: do we have a model?

artículo científico

High-dose chemotherapy with mitoxantrone + melphalan and autologous stem cell rescue in metastatic breast cancer patients: a study of feasibility and tolerability.

artículo científico publicado en 2003

High-dose etoposide enables the collection of peripheral blood stem cells in patients who failed cyclophosphamide-induced mobilization

scientific article published on 01 March 1998

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

scientific article published on 01 December 2006

Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study

artículo científico publicado en 2014

Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease

artículo científico publicado en 2011

Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.

artículo científico

Internal iliac artery perforation following bone marrow aspiration in a patient with no previously identified risk factors: a case report and review of the literature

artículo científico

Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.

artículo científico publicado en 2016

Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization

artículo científico

Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.

artículo científico publicado en 2013

Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry.

artículo científico publicado en 2012

Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control.

artículo científico publicado en 2015

Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.

artículo científico publicado en 2015

Modification of the content of plasma protein carbonyl groups in donors after granulocyte colony stimulating factor-induced stem cell mobilization

artículo científico publicado en 2005

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)

artículo científico publicado en 2020

Optimizing outcomes following allogeneic hematopoietic progenitor cell transplantation in AML: the role of hypomethylating agents.

artículo científico publicado en 2013

Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients.

artículo científico publicado en 2006

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.

artículo científico publicado en 2003

Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma

scientific article published on 24 July 2011

Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs.

artículo científico publicado en 2013

Plerixafor: what we still have to learn

artículo científico publicado en 2014

Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy.

artículo científico publicado en 2015

Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplanta

artículo científico publicado en 2015

Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation.

artículo científico publicado en 2005

Pulmonary micro-embolism in a healthy donor following G-CSF administration for mobilization of hemopoietic progenitor cells

artículo científico publicado en 2011

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials

scientific article published on 03 July 2019

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT

artículo científico publicado en 2022

Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patients

artículo científico publicado en 2014

Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents.

artículo científico publicado en 2015

Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.

artículo científico publicado en 2009

Smoldering multiple myeloma: to treat or not to treat.

artículo científico publicado en 2015

Sorafenib for the treatment of multiple myeloma.

artículo científico publicado en 2016

Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.

artículo científico publicado en 2002

The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation

artículo científico publicado en 2020

The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma

artículo científico publicado en 2016

The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation.

artículo científico publicado en 2012

The role of tandem stem cell transplantation for multiple myeloma patients

artículo científico

Thrombotic thrombocytopenic purpura: a rare late complication of allogeneic bone marrow transplantation.

artículo científico publicado en 1994

Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimen

artículo científico publicado en 2014

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab

artículo científico publicado en 2020

Two consecutive courses of rh-G-CSF-mobilized peripheral blood stem cells for primary marrow alloengraftment failure: case report

scientific article published on 01 September 1996

Utility of the clinical practice of administering thrombophilic screening and antithrombotic prophylaxis with low-molecular-weight heparin to healthy donors treated with G-CSF for mobilization of peripheral blood stem cells.

artículo científico publicado en 2007

Venetoclax for the treatment of chronic lymphocytic leukemia.

artículo científico publicado en 2017

Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study.

artículo científico publicado en 2014

Wernicke's encephalopathy after allogeneic stem cell transplantation

artículo científico publicado en 2007

[Magnetic resonance imaging of the bone marrow in aplastic anemia. Description of a case]

artículo científico publicado en 1993

Lista de obras de Massimo Martino

'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization

A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model

A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant

A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study

A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.

A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy

Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.

Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients

Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs.

An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma

An old drug with a new future: bendamustine in multiple myeloma.

An update on B-cell maturation antigen-targeted therapies in Multiple Myeloma

Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management?

Autologous stem cell transplantation in multiple myeloma is not dead but alive and well.

Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort Study.

Basiliximab for the treatment of graft rejection in haploidentical peripheral blood stem cell transplantation

Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia

Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review

Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma.

Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.

Diagnostic approaches for identifying acute graft-versus-host disease: what comes next?

Differences in transplant-related complications between hematologic malignancies and solid tumors receiving high-dose chemotherapy and autologous peripheral blood stem cell transplantation.

Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation

Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor

Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients

Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation

Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma

Graft-versus-lymphoma effect in a patient with a refractory low-grade lymphoma

Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim

High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry

High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study.

High-dose chemotherapy for germ cell tumors: do we have a model?

High-dose chemotherapy with mitoxantrone + melphalan and autologous stem cell rescue in metastatic breast cancer patients: a study of feasibility and tolerability.

High-dose etoposide enables the collection of peripheral blood stem cells in patients who failed cyclophosphamide-induced mobilization

High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients

Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study

Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease

Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity.

Internal iliac artery perforation following bone marrow aspiration in a patient with no previously identified risk factors: a case report and review of the literature

Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.

Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization

Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.

Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry.

Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control.

Mobilization of hematopoietic stem cells with lenograstim in healthy donors: efficacy and safety analysis according to donor age.

Modification of the content of plasma protein carbonyl groups in donors after granulocyte colony stimulating factor-induced stem cell mobilization

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)

Optimizing outcomes following allogeneic hematopoietic progenitor cell transplantation in AML: the role of hypomethylating agents.

Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients.

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.

Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma

Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs.

Plerixafor: what we still have to learn

Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy.

Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplanta

Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation.

Pulmonary micro-embolism in a healthy donor following G-CSF administration for mobilization of hemopoietic progenitor cells

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT

Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patients

Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents.

Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.

Smoldering multiple myeloma: to treat or not to treat.

Sorafenib for the treatment of multiple myeloma.

Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.

The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation

The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma

The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation.

The role of tandem stem cell transplantation for multiple myeloma patients

Thrombotic thrombocytopenic purpura: a rare late complication of allogeneic bone marrow transplantation.

Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimen

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab

Two consecutive courses of rh-G-CSF-mobilized peripheral blood stem cells for primary marrow alloengraftment failure: case report

Utility of the clinical practice of administering thrombophilic screening and antithrombotic prophylaxis with low-molecular-weight heparin to healthy donors treated with G-CSF for mobilization of peripheral blood stem cells.

Venetoclax for the treatment of chronic lymphocytic leukemia.